An in-depth look to DONGKOO BIO & PHARMA CO., LTD. operating, investing, and financing activities

006620 free cash flow for Q3 24 is 6.18 B KRW. For 2023, 006620 free cash flow was -10.26 B KRW and operating cash flow was 3.59 B KRW.